| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5649727 | Journal of Investigative Dermatology | 2017 | 4 Pages |
Abstract
Since 2009, the imiquimod- or Aldara-induced (3M Pharmaceuticals, St. Paul, MN) model of acute skin inflammation has become the most widely used mouse model in preclinical psoriasis studies. Although this model offers researchers numerous benefits, there are important limitations and possible confounding variables to consider. The imiquimod model requires careful consideration and warrants scrutiny of the data generated by its use. In this perspective, we provide an overview of the advantages and disadvantages of this mouse model and offer suggestions for its use in psoriasis research.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Jason E. Hawkes, Johann E. Gudjonsson, Nicole L. Ward,